FDA to Clarify Position on Off-Label Uses of Drugs
![](https://drugreporter.com/wp-content/uploads/2014/03/product-liability-risk-1-140x120.jpg)
Off-label use of prescription medications, a common practice that healthcare providers have long relied on and that pharmaceutical companies have profited from, has become the subject of a great deal of controversy. Billions in settlements have been paid out to patients who were allegedly harmed as a result of the off-label... Read more »